Johan M. Spoor - 04 Dec 2024 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Role: CEO, Director
Signature: /s/ Johan (Thijs) Spoor by Chris Nenno, as Attorney-in-Fact
Issuer symbol: CATX
Transactions as of: 04 Dec 2024
Net transactions value: +$30,132
Form type: 4
Filing time: 04 Dec 2024, 17:20:03 UTC
Previous filing: 04 Dec 2024
Next filing: 05 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CATX	Common Stock	Purchase	$30,132	+8,000	+28%	$3.77	36,257	04 Dec 2024	Direct	F1
holding	CATX	Common Stock						5,400	04 Dec 2024	By IRA of Reporting Person
holding	CATX	Common Stock						12,600	04 Dec 2024	By IRA of Spouse
holding	CATX	Common Stock						1,000	04 Dec 2024	By Child

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7596 to $3.7700, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transactions described in this footnote.

Content

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7596 to $3.7700, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transactions described in this footnote.